...
首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers
【24h】

A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers

机译:总血浆无细胞DNA用作晚期非小细胞肺癌患者对全身治疗反应的预测性生物标志物的前瞻性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

While previous studies have reported on the prognostic value of total plasma cell-free deoxyribonucleic acid (cfDNA) in lung cancers, few have prospectively evaluated its predictive value for systemic therapy response.
机译:虽然先前的研究报告了血浆中无血浆总脱氧核糖核酸(cfDNA)的预后价值,但很少有前瞻性评估其对全身治疗反应的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号